← Open Payments lookup

LOUIE ROSS: Open Payments

NPI 1801933031 · RICHLAND, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$565 in 16 payments from 9 companies in 2025. Trend: 2023 $933 · 2024 $636 · 2025 $565

Food & beverage: $565
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$151
Kowa Pharmaceuticals America, Inc.1$105
ABBVIE INC.4$93
Novo Nordisk Inc2$85
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$38
AstraZeneca Pharmaceuticals LP2$35
Amgen Inc.1$23
Phathom Pharmaceuticals, Inc.1$22
Boehringer Ingelheim Pharmaceuticals, Inc.1$14

Products named: CAPLYTA, ZORYVE, Ozempic, UBRELVY, XIFAXAN, AIRSUPRA, SYNTHROID, OTEZLA.

Industry payments across MS — which companies pay providers there.